leukemia

Dec 9, 2021

Rarecells Raises $13M in Series A Round to Develop Liquid Biopsy Early Cancer Detection Tests

Apr 22, 2021

Illumina, Kartos Therapeutics Partner to Develop TP53 Companion Diagnostic

Mar 12, 2021

COVID-19 Pandemic Changing Digital Innovations, Care Models for Lab Industry, Panelists Say at ACLA
Premium

Jan 14, 2021

Invitae, Pharma Firms Partner to Develop Standard MRD Panel for AML Clinical Trials

Nov 17, 2020

Cepheid Developing New Target for BCR-ABL Test for Leukemia Patients

Nov 13, 2020

Clinical Genomics Nabs Medicare Coverage for Colorectal Cancer Test as Novitas Revises LCD

Aug 17, 2020

Bionano Genomics Expecting Clinical Validation Studies to Drive Platform Adoption

Aug 10, 2020

Adaptive Biotechnologies Q2 Revenues Fall 5 Percent, Beat Analyst Estimates

Aug 6, 2020

Adaptive Biotechnologies Receives Expanded FDA Clearance for ClonoSeq MRD Assay

May 27, 2020

Illumina, Genomic Medicine Sweden to Evaluate Sequencing-Based Leukemia Diagnostics

May 21, 2020

Invivoscribe Receives Supplemental Approval for AML Kit

May 12, 2020

Adaptive Biotechnologies Q1 Revenues Grow 65 Percent

Feb 27, 2020

NeoGenomics Q4 Revenue Up 40 Percent

Feb 26, 2020

Adaptive Biotechnologies Q4 Revenues Rise 41 Percent

Jan 13, 2020

Adaptive Biotechnologies, Genentech Partner on MRD Testing in Venetoclax Clinical Trial

Jan 8, 2020

Adaptive Biotechnologies Gains Expanded Medicare Coverage for ClonoSeq

Dec 17, 2019

NeoGenomics Focused on Companion Diagnostics, NGS in 2020
Premium

Dec 11, 2019

At ASH, Researchers Discuss Rapid AML Nanopore Sequencing Assay for Analyzing Actionable Alterations

Dec 10, 2019

KU-Led Team Begins Clinical Validation of Microfluidic Device for Leukemia MRD Detection
Premium

Dec 4, 2019

Sight Dx Receives FDA Approval for CBC Analyzer, Plans US Commercial Rollout
Premium